Roussy Levy syndrome
Alternate names[edit]
Roussy Levy hereditary areflexic dystasia; Roussy-Levy disease; Hereditary areflexic dystasia; Charcot-Marie-Tooth Disease (Variant); Charcot-Marie-Tooth-Roussy-Levy Disease; Hereditary Motor Sensory Neuropathy I; HMSN I
Definition[edit]
Roussy Levy syndrome is a term used to describe a neuromuscular disorder that typically becomes apparent during early childhood. This syndrome is considered a form of Charcot-Marie-Tooth (CMT) disease.
Cause[edit]
Roussy Levy syndrome may result from a duplication of the PMP22 gene (which is also associated with CMT1A) or a mutation in the myelin protein zero (MPZ) gene (mutations in this gene are also associated with CMT1B).
Inheritance[edit]

Roussy Levy syndrome is inherited in an autosomal dominant manner.
Signs and symptoms[edit]
Individuals with this disorder have clinical symptoms similar to Charcot-Marie-Tooth (CMT) disease type 1, which is characterized by muscle weakness and atrophy, poor judgement of movement (sensory ataxia), absent reflexes (areflexia) of the lower legs and hands, and abnormally high arches of the feet (pes cavus or "clawfoot"). Additional features of rhythmic shaking (static tremor) in the hands and an unsteady gait (gait ataxia) are specific to Roussy Levy syndrome.
Clinical presentation[edit]
For most diseases, symptoms will vary from person to person. People with the same disease may not have all the symptoms listed.
80%-99% of people have these symptoms
- Areflexia(Absent tendon reflexes)
- Decreased motor nerve conduction velocity
- Decreased number of peripheral myelinated nerve fibers
- Distal amyotrophy(Distal muscle wasting)
- Gait disturbance(Abnormal gait)
- Hypertrophic nerve changes
- Hyporeflexia(Decreased reflex response)
Diagnosis[edit]
- Genetic testing for Roussy Levy syndrome (RLS) is available.
- RLS is one of the many different types of Charcot-Marie-Tooth disease (CMT).
- The genetics of the CMT disorders is complex.
- Once the different forms of CMT were classifed largely based upon their signs and symptoms.
- Now we know that alterations in the same gene can cause more than one type of CMT, and that a single type of CMT can be caused by alterations in more than one gene.
- RLS is caused by alterations in the MPZ or the PMP22 genes.
- Alterations in these genes can also cause other forms of CMT (Charcot-Marie-Tooth type 1 and 2, Dejerine–Sottas neuropathy, hereditary neuropathy with liability to pressure palsies, and congenital hypomyelinating neuropathy).
- A variety of other gene alterations have been implicated in other types of CMT (for example, CMT1 can also be caused by MP22, LITAF, EGR2, and NEFL gene alterations).
Treatment[edit]
There is a lack of published information regarding the treatment for this condition specifically; however, as Roussy Levy syndrome is considered a form of Charcot-Marie-Tooth (CMT) disease resembling CMT type 1, the symptoms may be managed in a similar manner. While there is no cure for CMT1, treatment is specific to the signs and symptoms present in each individual and may include:
- Special shoes, including those with good ankle support and ankle/foot orthoses (AFOs) to correct foot drop and aid walking
- Orthopedic surgery to correct severe pes cavus (high arches)
- Forearm crutches or canes for walking stability
- Serial night casting to help increase ankle flexibility
- Acetaminophen or nonsteroidal anti-inflammatory agents for musculoskeletal pain
- Antidepressants or anti seizure medications such as carbamazepine or gabapentin for neuropathic pain
- Beta blockers or primidone for tremors
- Physical therapy and occupational therapy
- Exercise within each individual's capability
- Additionally, there are certain medications that are potentially toxic to people with CMT as they may worsen CMT symptoms.
- The Charcot-Marie-Tooth Association (CMTA), an organization supporting CMT, maintains an updated list of medications that present varying risks for worsening CMT neuropathy.
NIH genetic and rare disease info[edit]
Roussy Levy syndrome is a rare disease.
| Rare and genetic diseases | ||||||
|---|---|---|---|---|---|---|
|
Rare diseases - Roussy Levy syndrome
|
Ad. Transform your health with W8MD Weight Loss, Sleep & MedSpa

Tired of being overweight?
Get started with evidence based, physician-supervised
affordable GLP-1 weight loss injections
Now available in New York City and Philadelphia:
- Semaglutide starting from $59.99/week and up
- Tirzepatide starting from $69.99/week and up (dose dependent)
✔ Evidence-based medical weight loss ✔ Insurance-friendly visits available ✔ Same-week appointments, evenings & weekends
Learn more:
Start your transformation today with W8MD weight loss centers.
|
WikiMD Medical Encyclopedia |
Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.
Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.
Translate this page: - East Asian
中文,
日本,
한국어,
South Asian
हिन्दी,
தமிழ்,
తెలుగు,
Urdu,
ಕನ್ನಡ,
Southeast Asian
Indonesian,
Vietnamese,
Thai,
မြန်မာဘာသာ,
বাংলা
European
español,
Deutsch,
français,
Greek,
português do Brasil,
polski,
română,
русский,
Nederlands,
norsk,
svenska,
suomi,
Italian
Middle Eastern & African
عربى,
Turkish,
Persian,
Hebrew,
Afrikaans,
isiZulu,
Kiswahili,
Other
Bulgarian,
Hungarian,
Czech,
Swedish,
മലയാളം,
मराठी,
ਪੰਜਾਬੀ,
ગુજરાતી,
Portuguese,
Ukrainian


